{
    "Trade/Device Name(s)": [
        "Atlas Multi-Drugs Screening Test Cup",
        "Atlas Multi-Drugs Screening Test Panel"
    ],
    "Submitter Information": "Atlas Medical",
    "510(k) Number": "K191099",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153050"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "JXN",
        "DIO",
        "DJC",
        "DJR",
        "DJG",
        "LCM",
        "LDJ",
        "LFG",
        "DNK"
    ],
    "Summary Letter Date": "May 9, 2019",
    "Summary Letter Received Date": "May 13, 2019",
    "Submission Date": "October 1, 2019",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3700",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3620",
        "21CFR862.3650",
        "21CFR862.3870",
        "21CFR862.3910",
        "21CFR862.3640"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Benzodiazepine Test System",
        "Propoxyphene Test System",
        "Cocaine and Cocaine Metabolite Test System",
        "Methamphetamine Test System",
        "Methadone Test System",
        "Opiate Test System",
        "Cannabinoid Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Morphine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Oxycodone",
        "Cocaine",
        "Nortriptyline",
        "Methamphetamine",
        "Phencyclidine",
        "Marijuana (THC)",
        "Secobarbital",
        "Oxazepam",
        "Methadone",
        "Propoxyphene",
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Test Cup",
        "Dip Card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow chromatographic immunoassay",
        "Competitive binding immunoassay",
        "Colloidal Gold Immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup",
        "Dip Card",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Atlas Multi-Drugs Screening Test Cup and Panel, lateral flow immunoassays for qualitative detection of up to 14 drugs of abuse in urine",
    "Indications for Use Summary": "Qualitative detection of drugs of abuse (up to 14 types) in urine for preliminary screening using lateral flow immunoassays, intended for professional use only; confirmation required by GC/MS",
    "fda_folder": "Toxicology"
}